Jason A. Mouabbi, Assistant Professor at MD Anderson Cancer Center, shared a post on X:
“Honored to have our PRE-I-SPY PRE2 trial featured at ASCO25. Grateful to Dr. Funda Meric-Bernstam for the spotlight on our work with Zanidatamab plus Tucatinib.”
